Universal Health Coverage (UHC) has garnered widespread attention since its inception. However, systematic research on the dynamic inequalities in UHC for Non-Communicable Diseases (NCDs) remains limited.
Methods
This study investigates the inequalities in UHC for NCDs from 2000 to 2021, offering evidence and policy recommendations to promote global UHC equality for NCDs. Using multiple cross-national datasets, this study examines UHC inequality for NCDs. A panel fixed-effects model analyzes influencing factors, while the Gini coefficient and other indices measure inequality. The Oaxaca-Blinder decomposition method identifies sources of inequality differences among countries with varying income levels.
Results
During this period, the global Non-Communicable Diseases Service Coverage Index (NCD-SCI) increased from the 50s to the 60s, while the Gini coefficient decreased from 0.115 to 0.095. Government health expenditure as a percentage of GDP significantly positively impacted NCD-SCI (β = 0.24, p < 0.01), whereas physician density per 10,000 people did not (95% CI included 0). The interaction between resource endowment and return rate contributed up to 53.26% to the SCI gap compared to low-income countries. Higher national income reduced the contribution of resource endowment differences to the SCI gap while increasing interaction effects. Differences between high-income and upper-middle-income countries were mainly due to health expenditure (contribution rate 116.67%), while those with low-income countries were driven by medical resource endowment.
Conclusion
This study reveals long-term trends in UHC for NCDs amid global economic disparities and proposes measures to enhance UHC levels and promote equality in different regions.
cross-national disparitiesinequalityNCDSSCIUHCThe author(s) declared that financial support was received for this work and/or its publication. This work was supported by the National Natural Science Foundation of China (NSFC) funded project (82104135).section-at-acceptancePublic Health PolicyIntroduction
Universal Health Coverage (UHC) (1), a pivotal target within the 2030 Agenda for Sustainable Development Goals (SDGs) (2), represents a shared objective for national governments and international organizations worldwide. Its vision aims to ensure that at least 80% of the global population gains access to quality health services by 2030 (3–5). Concurrently, it is committed to addressing health inequities—both within and between countries—through concerted efforts by governments and international bodies (2).
To quantify progress in UHC service coverage, the World Health Organization (WHO) and the World Bank jointly introduced the Service Coverage Index (SCI) in 2015 (6). The SCI utilizes 14 core indicators across four major service coverage domains—reproductive, maternal, newborn, and child health; infectious disease control; non-communicable diseases (NCDs); and service capacity and access—to measure member states’ advancement in delivering essential health services. This framework enables countries to identify gaps and inform policy interventions.
Particularly in recent years, NCDs—such as cardiovascular diseases, cancers, diabetes, and chronic respiratory diseases—have emerged as a priority focus within the context of UHC (7). Since the dawn of the 21st century, accelerated urbanization in lower middle-income countries (LMICs) (8, 9) has coincided with improved living standards. However, this progress has been counterbalanced by escalating NCD burdens in LMICs, attributable to widespread consumption of high-fat, high-salt, and high-sugar processed foods, reduced physical activity, and unhealthy cultural norms (10–12). These trends pose formidable challenges to individual health, household finances, and social development.
Currently, NCDs disproportionately contribute to the global disease burden, accounting for 73% of global deaths and 62% of the overall disease burden—a proportion that has risen continuously since 2000 (13). Although substantial progress in UHC was made over the past two decades, progress has stalled in recent years. Critically, since the inception of the Sustainable Development Goals era in 2015, the global SCI has increased by only three points (14). NCD management within UHC and primary healthcare (PHC) frameworks faces multifaceted challenges, characterized by: Limited resources, fragmented multi-sectoral PHC policies, inadequate financing, insufficient workforce capacity, incomplete essential service packages, ambiguous service delivery models, weak health information systems, barriers to diagnostic and medication access (15).
Additionally, under-investment in NCD research may exacerbate inequities in UHC across countries. In 2015, only 22% of countries had operational NCD research policies or programs; by 2019, approximately two-thirds of countries still lacked such frameworks, with a mere 4% of low-income countries adopting them (16). Consequently, NCD research priorities fail to fully align with population needs, and analyses of disparities within populations remain scarce. Concurrently, weak surveillance systems hinder effective NCD management. For instance, while the STEPS survey has been implemented in 120 countries, few nations repeat it every 5 years—as recommended by WHO (17). In 2019, only one-third of countries had robust cause-of-death mortality data systems, a disparity tightly correlated with national income groups: no low-income country possessed such systems, while over three-quarters of high-income countries did (18).
To address these gaps, this study leverages multiple transnational datasets to dissect global UHC performance for NCDs and its determinants. It compares disparities across income-based country groupings and proposes targeted recommendations, aiming to advance equitable UHC for NCDs worldwide.
MethodData source
This study assessed global inequalities in the NCD-SCI from 2000 to 2021 using multiple cross-national datasets under the UHC framework. The primary data sources were:
NCD-SCI: Data from the WHO’s Universal Health Coverage Monitoring Database, covering essential NCD interventions (hypertension treatment, diabetes management, and cancer screening) with a score range of 0–100. Observations were used for 2000, 2005, 2010, 2015, 2017, 2019, and 2021. (The raw data were obtained from: https://www.who.int/data/gho/data/major-themes/universal-health-coverage-major).
Government Health Expenditure: Percentage of GDP data from the World Bank (2000–2021), based on WHO’s Global Health Expenditure Database (GHED). (The raw data were obtained from: https://data.worldbank.org/topic/health).
Physicians per 10,000 Population: Data (2000–2021) from WHO’s Global Health Workforce Statistics Database. (The raw data were obtained from: https://www.who.int/data/gho/data/themes/topics/health-workforce).
World Bank Income Classification: Country economic groupings based on GNI and inflation-adjusted thresholds. The 2025 classification was used to match data from 2000 to 2021. (The raw data were obtained from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups).
GBD Database: NCD incidence, prevalence, DALYs, and mortality data (2021) from IHME’s GBD 2021 database, including sex-specific and combined estimates with 95% uncertainty intervals (UIs). (The raw data were obtained from: https://vizhub.healthdata.org/gbd-results/).
Data harmonization and processing
All datasets were merged using ISO Alpha-3 country codes, with manual verification to resolve inconsistencies. Multilateral datasets were consolidated by ISO Alpha-3 country codes after manual verification and resolution of naming inconsistencies. Country income groups follow World Bank classifications throughout. Economies lacking any SCI value were excluded from the outset. Missing physician-density observations were imputed within each country via linear interpolation using a custom safe approx routine in R; remaining gaps were replaced with the country-specific long-term mean. For government health-expenditure-to-GDP ratios, missing values were first interpolated within country. If interpolation was impossible, the following hierarchical imputation sequence was applied: (i) country mean, (ii) year-specific global mean, (iii) overall grand mean. The final analytical sample consists of 190 economies with complete SCI records and assigned income-group information.
Analysis of NCD burden
The study analyzed trends in NCD incidence, prevalence, DALYs, and mortality rates (including age-standardized rates, ASRs) globally from 2000 to 2021. Annual percentage changes (EAPCs) were calculated using a linear regression model y = α + βx + ε, where y = ln(ASR), x is the calendar year, and β represents the ASR trend. EAPC was derived as (exp(β) − 1) × 100%, with 95% confidence intervals (CIs) from the model. Trends were classified as increasing, decreasing, or stable based on EAPC and CI bounds (19, 20).
Panel fixed-effects model analysis of the NCD-SCI
A panel fixed-effects model (21) was constructed to examine factors influencing NCD-SCI and its dynamic characteristics. The base model controlled for time trends and individual heterogeneity:sci_stdit=α+β1doctors_per10k_stdit+β2health_exp_gdp_stdit+γt+εit
where i and t denote country and year, respectively; α is the constant term; β1 and β2 represent the coefficients of the number of physicians per 10,000 population and the percentage of health expenditure in GDP on the standardized SCI value, respectively; γtis the time fixed effect, which controls for common factors affecting all countries at different time points; and ϵit is the error term.
The model underwent multicollinearity tests, heteroscedasticity tests, autocorrelation tests, cross-sectional dependence tests, and RESET tests to ensure the robustness and reliability of the results.
Analysis of global inequality in NCD-SCI
Using balanced panel data (2000–2021), the study analyzed global inequalities in NCD-SCI through Gini coefficients (G=12μn2∑i=1n∑j=1n∣xi−xj∣, G ranges from [0, 1], with values closer to 1 indicating a higher degree of inequality. xi represents the SCI value of country i, μ denotes the global mean of SCI, and n is the number of countries) (22). To assess the trends in inequality as measured by the Gini coefficient, we employed the Theil index and the Atkinson index. Theil indices (T=∑i=1Nsi(xiμlnxiμ)), where i denotes the population weight of country i and Atkinson indices which is sensitive to the degree of inequality aversion, is also utilized to provide a comprehensive evaluation of inequality trends (23, 24). The Gini coefficient measured relative inequality, while absolute inequality was assessed via the P90–P10 gap. Inequalities were decomposed using the Oaxaca-Blinder method within a static panel fixed-effects model, with high-income countries as the baseline. Bootstrap sampling (1,000 replications) validated the results. Typical country cases within each income group were identified to highlight key inequality features.
All statistical analyses in this study were completed using R software (version 4.3.2).
ResultsAnalysis of NCD burden
Supplementary Tables S1–S4 displays the counts and age-standardized rates (ASRs) of incidence, prevalence, disability-adjusted life years (DALYs), and mortality for non-communicable diseases (NCDs) from 2000 to 2021. With 2000 as the baseline, it is observed that the burden of NCDs is gradually increasing year by year. Among them, although the standardized incidence and prevalence rates in females are higher than those in males, the age-standardized disability-adjusted life years rate (ASDR) and age-standardized mortality rate (ASMR) are much higher in males than in females (Figure 1). At the global level, the overall control of NCDs is good, with both ASDR and ASMR showing a downward trend. At the regional level, the East Asia and Pacific region has the highest increase in the age-standardized incidence rate (ASIR) of NCDs at 0.12%, while the Middle East and South Africa region has the largest decrease in ASIR at 0.04%. The age-standardized prevalence rate (ASPR) in the Europe and Central Asia region tends to be stable. The Europe and Central Asia region also has the highest decrease in ASDR and ASMR, at 1.25 and 1.87%, respectively. In contrast, South Asia has the lowest decrease in ASDR and ASMR, at 0.33 and 0.12%, respectively.
2000–2021 Non-communicable diseases’ trend. The number and ASR of incidence (a), prevalence (b) DALYs (c), and mortality (d) in 2000–2021 Non-communicable diseases’ trend.
Four bar graphs labeled a, b, c, and d compare yearly trends from 2000 to 2020 for males and females in incidence, prevalence, DALYs, and deaths. Each graph includes both raw numbers and age standardized rates, with color coding for gender and separate axes for number and rate, showing increases for all measures over time.Global panel fixed-effects model analysis of NCDs
Figure 2a shows that time fixed-effect values increase over time, indicating a significant positive impact of year on SCI during the study period, likely reflecting global progress in NCD prevention and control. Figure 2b reveals that the coefficient estimate for physicians per 10,000 population is not statistically significant (95% CI includes 0), while health expenditure as a percentage of GDP has a positive impact on SCI. Figure 2c indicates a good model fit, with points closely distributed near the 45-degree diagonal and small residuals.
Basic two-way fixed effects model. Trend chart of time fixed effects values (a), coefficient estimates (b), scatter plot of actual vs. predicted values (c).
Line chart labeled “a” shows time fixed effect values increasing from zero in 2000 to nearly one in 2021. Forest plot labeled “b” shows two variables, each with estimate dots and horizontal confidence intervals crossing zero. Scatter plot labeled “c” displays predicted versus actual values, with points concentrated along the diagonal, colored by residual magnitude from light to dark purple.
Model validation results are in Supplementary Figure S1.
Analysis of international inequality in the NCD-SCIDescriptive analysis of NCD-SCI
After matching the World Bank income groups with the NCD- SCI data provided by the World Health Organization, it was observed that the global distribution gap in universal health coverage among low-income countries has gradually narrowed compared to lower-middle-income countries and even showed a trend of surpassing the coverage rate of lower-middle-income countries in 2015. In contrast, although the universal health coverage rate in high-income countries has been increasing year by year, the overall room for improvement is limited, and a plateau phase even began in 2015 (see Figure 3) (The relevant test are shown in Supplementary Table S5).
2000–2021, Global NCD-SCI trend. Changes in the distribution of NCD-SCI values by income group from 2000 to 2021 (a), time-dependent dynamics of NCD-SCI mean and standard deviation across income groups from 2000 to 2021 (b).
Panel a shows a box plot comparing NCD-SCI values by income grouping from 2000 to 2021, with high income groups consistently scoring highest. Panel b presents a line graph of mean NCD-SCI values over time with standard deviation shading, again indicating higher values for higher income groups throughout the period.Analysis of global inequality trends in NCD-SCI
The global average NCD-SCI level rose from 50s to 60s, while the Gini coefficient decreased from 0.115 to 0.095, indicating a significant negative correlation between them. From 2000 to 2019, the degree of global NCD-SCI inequality improved, with narrowing disparities among countries (Figure 4a). The Theil index (<0.03) and Atkinson index (ε = 0.5, 0.15) both indicated mild inequality, supporting this finding. Future analyses should focus on a few extremely low-income countries and potential internal inequalities masked by policy (Supplementary Figure S2). From 2000 to 2021, global absolute NCD-SCI inequality showed varied trends across dimensions. The gap between the mean and median remained stable, suggesting no significant changes in the distribution structure of universal health coverage. The difference between the 90th and 10th percentiles was high in 2000 and gradually declined, stabilizing around 2020 (Figure 4b).
2000–2021, Global NCD-SCI inequality trend. Gini coefficient vs. global average SCI score (a), absolute gap over time by inequality indicator (b).
Panel a shows a line graph illustrating the decrease in Gini Coefficient as the Global Average SCI Score increases from 2000 to 2019, with year points labeled. Panel b presents two line graphs of inequality indicators from 2000 to 2020, with the orange line showing the P90–P10 Gap remaining higher and relatively steady, while the purple line for the Mean– Median Gap stays near zero.Oaxaca-blinder decomposition of inequality by income group based on panel fixed-effects model
To investigate factors influencing NCD-SCI inequality, this study used a panel fixed-effects model to decompose inequality by income group. Compared with high-income countries, low-income countries had a 145.65% contribution of medical resource difference (physicians per 10,000 population) to the SCI gap, while health expenditure difference contributed −45.65%, narrowing the gap. Lower-middle-income countries had a 42.86% contribution from medical resources and a 57.14% contribution from health expenditure, indicating significant physician shortages and a more pronounced impact of health expenditure insufficiency. Upper-middle-income countries showed a −16.67% contribution from medical resources, suggesting a minor impact on SCI, and a 116.67% contribution from health expenditure, highlighting the most significant impact of health expenditure insufficiency on SCI (Figure 5a).
Based on the aforementioned results, this study further decomposed the SCI gap. As shown in Figure 5b, when comparing high-income countries with low-income countries, the interaction effect contributed the most to the SCI gap at 53.26%, indicating that the interplay between resource endowment and the rate of return significantly exacerbated the gap between low-income and high-income countries. The difference in resource endowment contributed −46.62% to the SCI gap, suggesting that the overall shortage of resources in low-income countries is one of the main reasons for the SCI gap. When comparing high-income countries with lower-middle-income countries, the difference in resource endowment contributed the most to the SCI gap at 35.81%, followed by the interaction effect at −30.16%. When comparing high-income countries with upper-middle-income countries, the difference in resource endowment again contributed the most to the SCI gap at 15.66%, followed by the interaction effect at −10.70%, while the difference in the rate of return contributed the least at 1.15%.
Nevertheless, according to Supplementary Tables S6–S8, the difference in resource endowment was not significant between high-income and low-income countries, or between high-income and lower-middle-income countries, but it was significant between high-income and upper-middle-income countries, indicating that the resource level of the upper-middle-income group is closer to that of the high-income group. In terms of the difference in the rate of return and the interaction effect, the confidence intervals all included zero, and the differences between all groups were not significant. Overall, the differences between groups were mainly caused by the difference in resource endowment, especially between the high-income and upper-middle-income groups, while other influencing factors were relatively minor. For detailed data, please refer to Supplementary Tables S6–S8.
Oaxaca-Blinder decomposition. Percentage contribution of SCI disparities across different income groups (a), decomposition of SCI disparities (b).
Stacked bar chart with two panels comparing percentage contribution of healthcare resources to group comparisons by income. Panel a shows contributions from doctors (pink) and health expenditure (blue) for high income versus low, lower middle, and upper middle income groups, with values labeled for each bar. Panel b displays decomposition into resource endowment (pink), return rate differences (blue), and interaction effects (green) for the same group comparisons, each with numerical values labeled. Chart includes axes for percentage contribution and group comparison, with legends for each component.Analysis of typical countries
For countries with high levels of inequality as indicated by Gini coefficient comparisons, further analysis revealed that Sierra Leone, Micronesia, Tonga, and Nauru were identified as the most unequal countries in the low-income, lower-middle-income, upper-middle-income, and high-income groups, respectively (Supplementary Tables S9, S10). Despite their limited resources, countries such as Ghana, Nigeria, and Pakistan demonstrated relatively high resource utilization efficiency. Conversely, Nicaragua, Bolivia, and Colombia, despite having adequate resources, exhibited relatively low resource utilization efficiency. Moreover, some countries, such as Nepal and Micronesia, were found to be at a double disadvantage in terms of both resource availability and utilization efficiency (see Figure 6).
Healthcare resources and efficiency quadrant.
Scatter plot visualizing countries’ healthcare resource levels versus resource utilization efficiency, with data points colored by SCI level from blue (high) to yellow (low) and sized by contribution to group inequality, highlighting outliers like Nigeria, India, Honduras, and Kiribati, with quadrant annotations for resource and efficiency categorization.Discussion
This study systematically evaluates disparities in NCD burden and SCI within the framework of universal health coverage, utilizing comprehensive data spanning global, regional, and national scales from 2000 to 2021.
The findings indicate that the global NCD burden remained largely stabilized, with health inequalities showing improvement prior to the COVID-19 pandemic, while a modest resurgence in inequality trends was observed in the post-pandemic period (25). Regarding disease burden distribution, males bore a disproportionately higher burden of mortality and disability. Regionally, Europe and Central Asia achieved substantial declines in age-standardized death rates (ASDR), attributable to well-established healthcare systems and greater investment. Conversely, South Asia, East Asia, and the Pacific exhibited more pronounced increases in age-standardized incidence rates (ASIR), driven by rapid urbanization and lifestyle transitions, thus warranting enhanced control measures (26, 27).
Meanwhile, few studies have conducted modeling analyses on the SCI index, within the context of UHC. Globally, the SCI index has shown an upward trend over time, which may be associated with improvements in the global public health environment. Government health expenditure as a percentage of GDP exerts a significant positive impact on the SCI index, indicating that increasing health expenditure can effectively enhance the service coverage level for NCDs. In contrast, the impact of primary healthcare resources (i.e., the number of physicians per 10,000 population) is not significant, as observed in countries such as South Korea, Cyprus, Costa Rica, and Peru. The performance of these countries in terms of effective coverage varies substantially due to differences in per capita pooled health expenditure, highlighting that while increasing health expenditure is necessary, it alone is insufficient to improve the effective coverage rate of UHC. In other words, the efficiency of resource utilization may be more crucial than the total volume of resources. For instance, countries with limited resources, such as Ghana and Nigeria, have achieved better SCI performance than resource-abundant but inefficient countries like Nicaragua and Bolivia. This also explains why some countries have failed to effectively elevate NCD service coverage despite merely expanding the number of physicians (28, 29).
From the perspective of the developmental trend in coverage level, the UHC pertaining to NCDs has maintained a steady upward trajectory, while exhibiting notable disparities across income groups. Following the launch of the Sustainable Development Goals (SDGs) in 2015, low-income countries registered accelerated growth in this regard with international assistance. This phenomenon is closely associated with the financial input and priority focus areas during the SDG era and the Millennium Development Goals (MDGs) era (30). In particular, under the framework of the MDGs, sub-Saharan Africa secured increased financial support and policy preferences for HIV prevention and control, vaccination [e.g., measles vaccine and diphtheria-tetanus-pertussis (DPT) vaccine], the treatment of childhood infectious diseases (e.g., respiratory tract infections and diarrheal diseases), and maternal health services. The service coverage in these domains has been significantly improved, thereby accelerating the enhancement of the effective coverage index of UHC in sub-Saharan Africa (31) (with a year-on-year growth rate of 2.6% as of 2019).
A subgroup comparison using high-income countries as the baseline revealed that upper-middle-income countries have a relatively narrow gap with high-income countries in terms of resource endowments, and thus should prioritize targeted interventions (32). For instance, Peru has effectively improved the accessibility of primary healthcare services by increasing healthcare investment (a 15% growth in the healthcare budget in 2023, allocated to facility upgrading, personnel training, pharmaceutical procurement, and public health programs) and optimizing resource allocation (establishing special funds for rural healthcare and constructing new primary care clinics). In contrast, high-income countries have entered a developmental plateau with limited room for further improvement, as their NCD-SCI has already reached a high level (33, 34). Among them, the Republic of Korea has continuously optimized healthcare coverage through measures including the establishment of a nationwide unified healthcare insurance system, the refinement of the cost-sharing mechanism, and the setup of the National Evidence-based Healthcare Collaboration Agency (NECA). These efforts have provided mature experience for global practices in UHC (35).
It is worth noting that among the 17.3 million global NCD-related deaths in 2021, 86% of premature deaths occurred in lower-middle-income countries, whereas high-income countries have reaped the greatest benefits from the current pattern. This not only indicates that sustained expenditure and flexible resource allocation are pivotal to maintaining coverage equity, but also reveals the challenges inherent in achieving absolute equity (36). It follows that strategies should be tailored to the developmental stages of different countries: upper-middle-income countries (e.g., Peru) need to implement targeted interventions and optimize investment and resource distribution; high-income countries (e.g., the Republic of Korea) are expected to drive systemic innovations to provide mature experience for global practices (28, 29); low- and lower-middle-income countries, in turn, are in urgent need of a dual impetus from policy reform and technological innovation, so as to expand resource provision while improving efficiency, thereby narrowing the existing gaps. Specifically, targeted policies can be formulated to address the respective weaknesses of each country. For example, Viet Nam has strived to bridge urban–rural and regional resource gaps (37); Saudi Arabia has strengthened health interventions targeting populations with low educational attainment (38); and Sudan has developed tele-medicine services to ensure healthcare service continuity (39).
Going forward, to advance health equity, the WHO and countries worldwide must prioritize the issue of unequal resource allocation for NCDs. The advancement of the WHO Pandemic Agreement (WHOPA) (40) provides new opportunities for multilateral cooperation, developed countries should support recipient nations in enhancing their health technology capacity, while international organizations can focus on addressing service accessibility issues caused by geographical barriers through aid programs. The global community should collectively commit to optimizing resource allocation policies and implementing the One Health concept (41).
Conclusion
In conclusion, this study confirms that although NCD service coverage is constrained by multiple factors, targeted public health policy interventions are crucial. The core focus moving forward should be shifting from mere increases in investment to improving resource utilization efficiency, and leveraging international cooperation to target effective interventions at the most vulnerable regions and populations.
Data availability statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary material.
This is a short text to acknowledge the contributions of the World Health Organization (WHO) and the World Bank (WB) for providing the data that aided the efforts of the authors.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Correction note
A correction has been made to this article. Details can be found at: 10.3389/fpubh.2026.1817661.
Generative AI statement
The author(s) declared that Generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpubh.2026.1756485/full#supplementary-material
ReferencesWorld Health Organization. 2025. Universal health coverage. Available online at: https://www.who.int/health-topics/universal-health-coverage#tab=tab_11 (Accessed June 23, 2025)United Nations General Assembly. 2015. Transforming our world: the 2030 agenda for sustainable development. Available online at: https://www.refworld.org/legal/resolution/unga/2015/en/111816 (Accessed August 29, 2025)World Health Organization and World Bank Group. Monitoring progress towards Universal Health Coverage at country and global levels: framework, measures, and targets. Geneva: World Health Organization (2014).BoermaTAbou ZahrCEvansDEvansT. Monitoring intervention coverage in the context of universal health coverage. PLoS Med. (2014) 11:e1001728. doi: 10.1371/journal.pmed.1001728, 25243586ZhouYWuQLiCMengPDingL. Inequalities in non-communicable disease management in China and progress toward universal health coverage: an analysis of nationwide household survey data from 2004 to 2018. Lancet Reg Health West Pac. (2024) 44:100989. doi: 10.1016/S2214-109X(24)00044-7World Health Organization. Primary health care on the road to universal health coverage: 2019 global monitoring report. Geneva: World Health Organization (2019).FengZLiuXYangWPhillipsDR. Public expenditure on health care and the incidence of non-communicable diseases (NCDs) in China from 2008 to 2018. Maturitas. (2024) 183:107963. doi: 10.1016/j.maturitas.2024.107963, 38471332ChakmaTKarimSRabbaniA. Examining the association between service coverage of UHC and global disease burden: a cross-country panel analysis. Soc Sci Med. (2025) 369:117832. doi: 10.1016/j.socscimed.2025.117832, 39983246NCD Countdown 2030 collaborators. NCD countdown 2030: efficient pathways and strategic investments to accelerate progress toward the sustainable development goal target 3.4 in low-income and middle-income countries. Lancet. (2022) 399:1266–78. doi: 10.1016/S0140-6736(22)00267-3AllenLNWigleySHolmerH. Implementation of non-communicable disease policies from 2015 to 2020: a geopolitical analysis of 194 countries. Lancet Glob Health. (2021) 9:e1528–38. doi: 10.1016/S2214-109X(21)00303-6, 34678197ZhouYWuQLiCMengPDingL. Inequalities in non-communicable disease management in China and progress toward universal health coverage: an analysis of nationwide household survey data from 2004 to 2018. Lancet Reg Health West Pac. (2023) 44:100989. doi: 10.1016/j.lanwpc.2023.100989NCD Countdown 2030 Collaborators. NCD countdown 2030: worldwide trends in non-communicable disease mortality and progress towards sustainable development goal target 3.4. Lancet. (2018) 392:1072–88. doi: 10.1016/S0140-6736(18)31992-5GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet. (2024) 403:2133–61. doi: 10.1016/S0140-6736(24)00757-8World Health Organization and World Bank. Tracking Universal Health Coverage: 2023 global monitoring report. Geneva: World Health Organization (2023).World Health Organization. Report of the first meeting of the strategic and technical advisory group for noncommunicable diseases: virtual meeting, 27–28 October 2021. Geneva: World Health Organization (2021).GibbsNKwonJBalenJDoddPJ. Operational research to support equitable non-communicable disease policy in low-income and middle-income countries in the sustainable development era: a scoping review. BMJ Glob Health. (2020) 5:e002259. doi: 10.1136/bmjgh-2019-002259, 32605934World Health Organization In: World Health Organization, editor. STEPS site report. Geneva: (2022). Available online at: https://www.who.int/news/item/12-05-2022-new-report-shows-progress-and-missed-opportunities-in-the-control-of-ncds-at-the-national-levelWorld Health Organization. Tracking Universal Health Coverage: 2023 global monitoring report. Geneva: World Health Organization (2024).CaoFXuZLiXXFuZYHanRYZhangJL. Trends and cross-country inequalities in the global burden of osteoarthritis, 1990–2019: a population-based study. Ageing Res Rev. (2024) 99:102382. doi: 10.1016/j.arr.2024.102382, 38917934LiuZJiangYYuanHFangQCaiNSuoC. The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. (2019) 70:674–83. doi: 10.1016/j.jhep.2018.12.001, 30543829WooldridgeJM. Econometric analysis of cross section and panel data. 2nd ed. Cambridge, MA: Massachusetts Institute of Technology Press (2010).GsteigerSLowNSonnenbergPMercerCHAlthausCL. Gini coefficients for measuring the distribution of sexually transmitted infections among individuals with different levels of sexual activity. PeerJ. (2020) 8:e8434. doi: 10.7717/peerj.8434, 31998566SunJWuHShiS. A research of the evaluation of preschool education resource allocation level and spatio - temporal differences: based on repeated indicators method and Theil index. Heliyon. (2023) 9:e16362. doi: 10.1016/j.heliyon.2023.e16362, 37274700De MaioFG. Income inequality measures. J Epidemiol Community Health. (2007) 61:849–52. doi: 10.1136/jech.2006.052969, 17873219AndradeCASMahrousehNGabraniJCharalampousPCuschieriSGradDA. Inequalities in the burden of non - communicable diseases across European countries: a systematic analysis of the global burden of disease 2019 study. Int J Equity Health. (2023) 22:140. doi: 10.1186/s12939-023-01958-8, 37507733WagstaffADmytraczenkoTAlmeidaGBuismanLHoang-Vu EozenouPBredenkampC. Assessing Latin America’s progress toward achieving universal health coverage. Health Aff. (2015) 34:1704–12. doi: 10.1377/hlthaff.2014.1453, 26438747OhJKimMJHurSOhJKimDS. Institutionalizing health technology assessment and priority setting in South Korea's Universal Health Coverage journey. Health Syst Reform. (2024) 9:2338308. doi: 10.1080/23288604.2024.2338308, 38715186World Health Organization. Primary health care on the road to universal health coverage: 2019 monitoring report. Geneva: World Health Organization (2019).GasparRSRossiLHoneTDornellesAZ. Income inequality and non - communicable disease mortality and morbidity in Brazil states: a longitudinal analysis 2002 - 2017. Lancet Reg Health Am. (2021) 2:100042. doi: 10.1016/j.lana.2021.100042, 36779037AtunRde AndradeLOAlmeidaGCotlearDDmytraczenkoTFrenzP. Health-system reform and universal health coverage in Latin America. Lancet. (2015) 385:1230–47. doi: 10.1016/S0140-6736(14)61646-9GBD 2019 Universal Health Coverage Collaborators. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. (2020) 396:1250–84. doi: 10.1016/S0140-6736(20)30750-9, 32861314SchmidtMIDuncanBBGA e SMenezesAMMonteiroCABarretoSM. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet. (2011) 377:1949–61. doi: 10.1016/S0140-6736(11)60135-9, 21561658HoganDRStevensGAHosseinpoorARBoermaT. Monitoring universal health coverage within the sustainable development goals: development and baseline data for an index of essential health services. Lancet Glob Health. (2018) 6:e152–68. doi: 10.1016/S2214-109X(17)30472-2, 29248365WagstaffANeelsenS. A comprehensive assessment of universal health coverage in 111 countries: a retrospective observational study. Lancet Global Health. (2020) 8:e39–49. doi: 10.1016/S2214-109X(19)30463-2, 31837954VelásquezASuarezDNepo-LinaresE. Reforma del sector salud en el Perú: Derecho, gobernanza, cobertura universal y respuesta contra riesgos sanitarios [Health sector reform in Peru: law, governance, universal coverage, and responses to health risks]. Rev Peru Med Exp Salud Publica. (2016) 33:546–55. doi: 10.17843/rpmesp.2016.333.2338, 27831620KroflinKGonzalez UtrillaMMooreMLomazziM. Protecting the healthcare workers in low- and lower-middle-income countries through vaccination: barriers, leverages, and next steps. Glob Health Action. (2023) 16:2239031. doi: 10.1080/16549716.2023.2239031, 37496447LeDDLeon-GonzalezRGiangTLNguyenAT. Socio-economic-related health inequality in non-communicable diseases among older people in Viet Nam. Ageing Soc. (2021) 41:1421–48. doi: 10.1017/S0144686X19001843Al-HanawiMKKeetileM. Socio-economic and demographic correlates of non-communicable disease risk factors among adults in Saudi Arabia. Front Med. (2021) 8:605912. doi: 10.3389/fmed.2021.605912, 33889582World Health Organization In: World Health Organization, editor. Sudan: remote health services provision during the COVID-19 pandemic. Geneva: (2024)World Health Organization (2025). WHO pandemic agreement (WHA78.1). Geneva: WHO. Available online at: https://apps.who.int/gb/ebwha/pdf_files/WHA78/A78_R1-en.pdf (Accessed January 12, 2026).World Health Organization (n.d.). One health. Available online at: https://www.oie.int/en/what-we-do/global-initiatives/one-health/ (Accessed January 12, 2026).
Edited by: Fahad Hanna, Torrens University Australia, Australia
Reviewed by: Lu Liu, Chinese Academy of Medical Sciences and Peking Union Medical College, China
Lawal Abdulwahab Olamilekan, Universiti Brunei Darussalam, Brunei
GlossaryASDR
Age-standardized disability-adjusted life years rate
ASIR
Age-standardized incidence rate
ASMR
Age-standardized mortality rate
ASPR
Age-standardized prevalence rate
ASR
Age-standardized rate
CI
Confidence interval
DALYs
Disability-adjusted life years
DTP
Diphtheria-tetanus-pertussis
EAPC
Estimated annual percentage change
GBD
Global burden of disease
GHED
Global health expenditure database
GNI
Gross national income
IHME
Institute for Health Metrics and Evaluation
LMICs
Lower middle-income countries
MDGs
Millennium development goals
NCD-SCI
Non-Communicable diseases service coverage index
NCDs
Non-Communicable diseases
NECA
National evidence-based healthcare collaboration agency